This is a clinical trial for
Patients with lupus

This study is for people with CLE (cutaneous lupus erythematosus) and/or SLE (systemic lupus erythematosus). People with certain types of lupus may experience skin rashes, sores, scarring, or inflammation. The investigational drug in this study targets the specific cells involved in causing these skin symptoms. This study will evaluate the safety of the drug and whether it may reduce these skin issues in patients with CLE, and may decrease overall lupus symptoms, such as fatigue and joint pain, in patients

Check if you’re eligible

How old are you?

What is your sex?

Are you pregnant, breastfeeding, or planning to become pregnant?

Has a doctor diagnosed you with lupus?

Which type of lupus have you been diagnosed with?

Do you experience pain or swelling in your joints?

Do you currently have any of the following?

Do you currently have any of the following conditions? Please select all that apply.

Have you ever had cancer?

What type of cancer did you have?

When did you have this cancer?

Are you currently taking, or have you ever taken, any of the following medications?

Please select the most convenient location for you to attend study visits.

Just a moment!